Non-oncogenic addicted NSCLC patients: What is the best approach?

Date 27 September 2014
Event ESMO 2014
Session Systemic treatment of metastatic NSCLC
Topics Anticancer agents
Non-Small Cell Lung Cancer
Therapy
Biological Therapy
Presenter Benjamin Besse
Authors B. Besse
  • Dept. Of Medicine, Institut de Cancérologie Gustave Roussy, 94805 - Villejuif/FR